HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HRID 368853Erstellt: 25. Oktober 2026
2-(2-Bromophenyl)ethan-1-ol → 1-(4-Methoxyphenyl)-4-[2-(5-bromoisochroman-1-yl)ethyl]piperazine
https://huagongshe.com/reaction/368853
Beteiligte Stoffe
| Rolle | Name | HCID | Einwaage |
|---|
| Edukt | 2-(2-Bromophenyl)ethan-1-ol | HCID 2734089 | — |
| Edukt | p-Methoxyphenylpiperazine | HCID 23170892 | — |
| Edukt | Ethyl 2-(5-bromoisochroman-1-yl)acetate | HCID 23288918 | — |
| Edukt | 2-(5-Bromoisochroman-1-yl)acetic acid | HCID 23288919 | — |
| Edukt | 1-(4-Methoxyphenyl)-4-[2-(5-bromoisochroman-1-yl)]acetyl piperazine | HCID 57128380 | — |
| Produkt | 1-(4-Methoxyphenyl)-4-[2-(5-bromoisochroman-1-yl)ethyl]piperazine | HCID 23288744 | — |
Reaktionsschritte
Following the general procedure of EXAMPLE 45 (step 1) and making non-critical variations 2-(o-bromophenyl)-1-ethanol (XLIX, 3.3 g) is converted to ethyl 2-(5-bromoisochroman-1-yl)acetate (LXXI). Following the general procedure of EXAMPLE 45 (Step 2) and making non-critical variations ethyl 2-(5-bromoisochroman-1-yl)acetate (LXXI, 1.0 g) is hydrolyzed to the corresponding acid, 2-(5-bromoisochroman-1-yl)acetic acid (LXXII). The acid (LXXII, 740 mg) is coupled with p-methoxyphenylpiperazine (V) and the resulting amide, 1-(4-methoxyphenyl)-4-[2-(5-bromoisochroman-1-yl)]acetyl piperazine (LXXIII, 1.10 g) is reduced according to the general procedure described in EXAMPLE 50 (making non-critical variations) to give the title compound, mp 105-106°.
Herkunft & Nachweise
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patentnummer | US06133446 |
|---|
| Quelldatensatz | uspto-grants-2000_10 |
|---|
| ORD ID | ord-e0e982fff3ec479b9cc691d14e90c825 |
|---|
| Quellennotiz | uspto-grants-2000_10 |
|---|